These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6545280)
21. Chemistry and DNA alkylation reactions of aziridinyl quinones: development of an efficient alkylating agent of the phosphate backbone. Skibo EB; Xing C Biochemistry; 1998 Oct; 37(43):15199-213. PubMed ID: 9790684 [TBL] [Abstract][Full Text] [Related]
22. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity. Müller L; Gocke E; Lavé T; Pfister T Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141 [TBL] [Abstract][Full Text] [Related]
23. Binding of (chloroethyl 3H) cyclophosphamide to rat embryo proteins: two-dimensional gel analysis. Mirkes PE; Little SA Teratology; 1990 Feb; 41(2):195-204. PubMed ID: 1690924 [TBL] [Abstract][Full Text] [Related]
24. Immunochemical and GC/MS analysis of protein adducts: dosimetry studies with ethylene oxide. Britton DW; Törnqvist M; van Sittert NJ; Watson WP; Wraith MJ; Wright AS Prog Clin Biol Res; 1991; 372():99-106. PubMed ID: 1956952 [No Abstract] [Full Text] [Related]
25. Reichardt's dye and its reactions with the alkylating agents 4-chloro-1-butanol, ethyl methanesulfonate, 1-bromobutane and Fast Red B - a potentially useful reagent for the detection of genotoxic impurities in pharmaceuticals. Corrigan DK; Whitcombe MJ; McCrossen S; Piletsky S J Pharm Pharmacol; 2009 Apr; 61(4):533-7. PubMed ID: 19298702 [TBL] [Abstract][Full Text] [Related]
26. Monitoring human exposure to ethylene oxide by the determination of haemoglobin adducts using gas chromatography-mass spectrometry. Farmer PB; Bailey E; Gorf SM; Törnqvist M; Osterman-Golkar S; Kautiainen A; Lewis-Enright DP Carcinogenesis; 1986 Apr; 7(4):637-40. PubMed ID: 3698196 [TBL] [Abstract][Full Text] [Related]
27. Identification of endogenous electrophiles by means of mass spectrometric determination of protein and DNA adducts. Farmer PB; Bailey E; Naylor S; Anderson D; Brooks A; Cushnir J; Lamb JH; Sepai O; Tang YS Environ Health Perspect; 1993 Mar; 99():19-24. PubMed ID: 8319621 [TBL] [Abstract][Full Text] [Related]
28. The binding of beta-propiolactone and some related alkylating agents to DNA, RNA, and protein of mouse skin; relation between tumor-initiating power of alkylating agents and their binding to DNA. Colburn NH; Boutwell RK Cancer Res; 1968 Apr; 28(4):653-60. PubMed ID: 5649056 [No Abstract] [Full Text] [Related]
29. Alkylation of prohibitin by cyclohexylphenyl-chloroethyl urea on an aspartyl residue is associated with cell cycle G(1) arrest in B16 cells. Bouchon B; Papon J; Communal Y; Madelmont JC; Degoul F Br J Pharmacol; 2007 Oct; 152(4):449-55. PubMed ID: 17704829 [TBL] [Abstract][Full Text] [Related]
30. Repair of alkylated DNA: recent advances. Sedgwick B; Bates PA; Paik J; Jacobs SC; Lindahl T DNA Repair (Amst); 2007 Apr; 6(4):429-42. PubMed ID: 17112791 [TBL] [Abstract][Full Text] [Related]
31. Carcinogenic consequences of DNA alkylation. Michejda CJ Contrib Gynecol Obstet; 1991; 18():71-8. PubMed ID: 1935129 [No Abstract] [Full Text] [Related]
32. [Biological monitoring of exposure to alkylating xenobiotics by determining them in complexes with plasma proteins, hemoglobin, mercapturic acids from urine of rats and industrial workers. I. Acrylonitrile]. Ivanov VV; Hashimoto K; Inomata K; Kawai T; Mizunuma K; Klimatskaia LG Vopr Med Khim; 1995; 41(4):18-22. PubMed ID: 8571578 [TBL] [Abstract][Full Text] [Related]
33. Determinants of selectivity in alkylation of nucleosides and DNA by secondary diazonium ions: evidence for, and consequences of, a preassociation mechanism. Blans P; Fishbein JC Chem Res Toxicol; 2004 Nov; 17(11):1531-9. PubMed ID: 15540951 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of genetic risks of alkylating agents. III. Alkylation of haemoglobin after metabolic conversion of ethene to ethene oxide in vivo. Ehrenberg L; Osterman-Golkar S; Segerbäck D; Svensson K; Calleman CJ Mutat Res; 1977 Nov; 45(2):175-84. PubMed ID: 593285 [TBL] [Abstract][Full Text] [Related]
35. Analysis of hemoglobin as a dose monitor for alkylating and arylating agents. Neumann HG Arch Toxicol; 1984 Nov; 56(1):1-6. PubMed ID: 6517706 [TBL] [Abstract][Full Text] [Related]
36. Molecular dosimetry techniques in human risk assessment: an industrial perspective. Wright AS Dev Toxicol Environ Sci; 1983; 11():311-8. PubMed ID: 6329628 [No Abstract] [Full Text] [Related]
37. Detection and characterization of two major ethylated deoxyguanosine adducts by high performance liquid chromatography, electrospray mass spectrometry, and 32P-postlabeling. Development of an approach for detection of phosphotriesters. Singh R; Sweetman GM; Farmer PB; Shuker DE; Rich KJ Chem Res Toxicol; 1997 Jan; 10(1):70-7. PubMed ID: 9074805 [TBL] [Abstract][Full Text] [Related]
38. N-t-butyliodoacetamide and iodoacetanilide: two new cysteine alkylating reagents for relative quantitation of proteins. Pasquarello C; Sanchez JC; Hochstrasser DF; Corthals GL Rapid Commun Mass Spectrom; 2004; 18(1):117-27. PubMed ID: 14689568 [TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human. Lavé T; Birnböck H; Götschi A; Ramp T; Pähler A Toxicol Lett; 2009 Nov; 190(3):303-9. PubMed ID: 19695315 [TBL] [Abstract][Full Text] [Related]
40. Alkylation of inorganic oxo compounds and insights on preventing DNA damage. Hamilton EE; Fanwick PE; Wilker JJ J Am Chem Soc; 2006 Mar; 128(10):3388-95. PubMed ID: 16522120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]